COMMUNIQUÉS West-GlobeNewswire

Nkarta Reports Second Quarter 2026 Financial Results and Corporate Highlights
10/08/2026
Enrollment continues across all indications in Ntrust-1 and Ntrust-2 at the 4 billion cell dose level (12 billion cells in 3-dose cycle) Initial clinical data from Ntrust-1 and Ntrust-2 expected to be presented at a [...]
SCYNEXIS Reports Second Quarter 2026 Financial Results and Provides Corporate Update
10/08/2026
Initiated a Phase 1 study of SCY-770, a first-in-class, potent and direct AMPK activator for treatment of ADPKD; topline data are expected in Q3 2026 and are anticipated to inform dose selection for the planned Phase 2 [...]
Essential Amino Acid Intake Draws Focus During GLP-1 Therapy as Oh!mino Targets Muscle Loss
10/08/2026
Seal Beach, CA, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Oh!Nutrition, a California-based nutritional product development company, today announced Oh!mino® Muscle Synthesis Activator, an essential amino acid supplement [...]
Interpace Biosciences Announces Second Quarter 2026 Financial and Business Results
10/08/2026
Q2 Revenue of $9.1 million Q2 Income from Continuing Operations of $0.3 million Q2 Thyroid volume year-over-year increase of 6% Q2 Thyroid revenue year-over-year increase of 9% Trailing twelve-month thyroid revenue of $ [...]
Dallas Hair Replacement for Business Professionals Offers Non-Surgical Hair Replacement for Men
10/08/2026
Look Sharp, Stay Competitive. Restore your confidence with non-surgical hair replacement in Dallas. Dallas, TX, Aug. 10, 2026 (GLOBE NEWSWIRE) -- In the competitive business environment of Dallas, confidence and success [...]
Silo Pharma Granted European Patent Covering Novel PTSD Therapy
10/08/2026
Patent strengthens global IP protection for novel treatment approach designed to prevent stress-induced psychiatric disorders before symptoms develop SARASOTA, FLA., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Silo Pharma (Nasdaq [...]
Vystar Completes Acquisition of R3ALM Financial Ecosystem, Targets $120 Million Tokenized Equity Launch
10/08/2026
■ ■ ■ Consideration includes approximately 8,371 shares of Vystar Series B preferred stock Parties intend to jointly manage and develop the R3alm platform R3alm is being developed as a compliance-focused ecosystem [...]
Autonomix Medical Congratulates Co-Founder & Chief Medical Officer Dr. Robert Schwartz on Receiving Prestigious 2026 Cardiovascular Tech Forum Lifetime Achievement Award
10/08/2026
Recognition honors one of the medical technology industry's most influential innovators, whose career has helped shape modern cardiovascular care THE WOODLANDS, TX, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, [...]
Baird Medical and Alpmed Enter Strategic Partnership to Advance Irreversible Electroporation (IRE) Technology Globally
10/08/2026
Agreement combines Baird Medical's clinical, regulatory, and global commercialization expertise with Alpmed's leadership in IRE technology Collaboration will advance technology development, global regulatory approvals, [...]
Wave Life Sciences Announces Completion of Redomiciliation to Delaware
10/08/2026
CAMBRIDGE, Mass., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences, Inc. (NASDAQ: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health (“ [...]
Capricor Therapeutics to Report Second Quarter 2026 Financial Results and Provide Recent Corporate Update on August 13
10/08/2026
– Company to Host Conference Call on August 13, 2026, at 4:30 p.m. ET – SAN DIEGO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and [...]
TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Second Quarter 2026 Financial Results on August 14, 2026
10/08/2026
FREDERICK, Md., Aug. 10, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions today announced it will report results for the second [...]
Kura Oncology Announces Publication in Blood Highlighting Ziftomenib’s Differentiated Binding Profile and Preclinical Activity
10/08/2026
– Publication details the discovery and preclinical characterization of ziftomenib, including its potency, selectivity, and mechanism of action – – Findings demonstrate differentiated menin binding and activity against [...]
AIM ImmunoTech Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution Advancing Ampligen® Toward Planned Phase 3 Development in Pancreatic Cancer
10/08/2026
Completed Enrollment and Ampligen Dosing in Metastatic Pancreatic Cancer Phase 2 Trial, Positioning Company for Key Clinical Milestones Through Early 2027 Pancreatic Cancer Remains Strategic Priority as AIM Advances [...]
CMS Proposed 2027 Medicare Policy Continues Recognition of the FDA’s Section 351 Biologic Pathway
10/08/2026
Applied Biologics believes rigorous scientific development and regulatory standards are essential to advancing innovation in chronic wound care SCOTTSDALE, Ariz., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, a [...]
Artelo Announces Enrollment of First Patient in a Phase 2 Clinical Trial Evaluating ART27.13 for Treatment of Glaucoma
10/08/2026
Investigator-led study funded by Glaucoma UK and the HSC R&D Division expands ART27.13’s clinical potential into ophthalmology Initial DREAM Study Results Anticipated in Q4 2026 SOLANA BEACH, Calif., Aug. 10, 2026 ( [...]
PerfectServe Ushers in New Era of AI in Voice with Intelligent Answering powered by ConnectiveIQ
10/08/2026
AI answering service draws on 30 years of clinical workflow expertise and features the first application of Sloane, PerfectServe’s virtual AI agent MIAMI, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Most answering services can [...]
Xcellon Biologics Acquires GMP Manufacturing Facility from NextCure, Becoming an End-to-End CRDMO for Next-Generation Bioconjugates and Complex Biologics
10/08/2026
Acquisition of the GMP biologics manufacturing facility expands Xcellon’s integrated capabilities from discovery through clinical supply and strengthens U.S. biomanufacturing BELTSVILLE, Md., Aug. 10, 2026 (GLOBE [...]
Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage
10/08/2026
Seasoned biotechnology founder, public company CFO and corporate strategist brings more than 25 years of leadership in oncology, capital markets, M&A and corporate governance Appointment further strengthens [...]

Pages